Med-Chemist : "Quintessential Medicinal Chemistry"
Monday, August 8, 2011
FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis
FDA Accepts NDA Filing for Ruxolitinib as a Treatment for Myelofibrosis
Newer Post
Older Post
Home